Stay updated on Pembrolizumab in Advanced Gastric Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Advanced Gastric Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Advanced Gastric Cancer Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    Added explicit mention of Gastric cancer and a Resources section linking to the Genetic and Rare Diseases Information Center; these are informational updates that do not alter core study details or navigation. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-18T06:43:36.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    Revision: v3.4.2 added and the funding notice was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T05:08:50.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    A site-wide notice regarding a lapse in government funding was added to the page, and the page revision updated from v3.4.0 to v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-04T04:41:23.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    A glossary is now displayed to help users understand terms on the page. QC metadata has been updated to show Last Update Submitted that Met QC Criteria and the new revision label (v3.4.0), replacing the previous QC label (Last Update Submitted that met QC Criteria) and the older revision.
    Difference
    0.2%
    Check dated 2026-01-28T03:01:12.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4. No study content or user-facing functionality appears to be affected.
    Difference
    0.0%
    Check dated 2026-01-14T01:50:23.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    The page now includes a new Revision: v3.3.3 and removes HHS Vulnerability Disclosure and Revision: v3.3.2 from the footer, which are maintenance/versioning updates rather than trial data changes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-23T17:29:01.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Advanced Gastric Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Advanced Gastric Cancer Clinical Trial page.